Bio-Path Holdings announces 1-for-20 reverse stock split effective Feb 22, 2024

BIO-PATH HOLDINGS, INC.

Reverse split ratio 1-for-20 effective 5:30 p.m. ET Feb 22, 2024; trading starts split-adjusted on Nasdaq under BPTH on Feb 23.
Shares outstanding reduced from ~12.35M to ~617,833; no fractional shares issued.
New CUSIP number 09057N409; par value unchanged; all options/warrants adjusted.
Company uses DNAbilize antisense RNAi nanoparticle tech for cancer drugs.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BIO-PATH HOLDINGS, INC.: Filed Certificate of Amendment to effect a one-for-twenty reverse stock split of Common Stock (effective 2024-02-22).

Change: charter amendment
Effective: 2024-02-22

Exact text from the filing

On February 22, 2024, Bio-Path Holdings, Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to the Company’s Certificate of Incorporation with the Delaware Secretary of State to effect a reverse stock split of the Company’s Common Stock, par value $0.001 (the “Common Stock”) at a ratio of one-for-twenty, effective at 5:30 p.m. Eastern Time on February 22, 2024 (the “Reverse Stock Split”) .

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

BIO-PATH HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001558370-24-001573

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.